mRNA-1018 for H5N8
/ Moderna
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 09, 2024
A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults
(clinicaltrials.gov)
- P1/2 | N=1504 | Completed | Sponsor: ModernaTX, Inc. | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Influenza • Respiratory Diseases
January 31, 2024
A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults
(clinicaltrials.gov)
- P1/2 | N=1504 | Active, not recruiting | Sponsor: ModernaTX, Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases
August 02, 2023
A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults
(clinicaltrials.gov)
- P1/2 | N=1500 | Recruiting | Sponsor: ModernaTX, Inc.
New P1/2 trial • Infectious Disease • Influenza • Respiratory Diseases
1 to 3
Of
3
Go to page
1